In the absence of any indication to the contrary, the Commission therefore considers that restriction to professional users is an appropriate and available risk mitigation measure for the authorisation of products containing difethialone in Germany.
Kuna vastupidise tõendamiseks tõendeid ei ole, leiab komisjon, et kasutamise piiramine üksnes kutseliste kasutajatega on sobiv ja kättesaadav riskivähendamismeede seoses lubade andmisega difetialooni sisaldavate toodete kasutamiseks Saksamaal.